Headline payments revenue obscures net economics, loss-making cohorts, and true processor cost.
What is the normalized margin baseline, and which cost-side levers can support an EBITDA-lift case?
Buy & Sell-Side Diligence
A 1 to 3 week payments diagnostic for financial sponsors. We validate the target’s payments economics before close and give the investment committee a model it can pressure-test.
Read by the investment committee: four to six slides, a model your analyst can pressure-test, and a watch-items list.
Buy-side underwriting for a sponsor evaluating a vertical-SaaS target with embedded payments.
Sell-side preparation is available through banker channels. Buy-side underwriting and sell-side preparation use different evidence boundaries.
Straata turns the data room into a normalized baseline, confidence-ranked scenarios, and the watch items that can change the bid, market story, or first 100 days.
When payments can change the bid, the story, or the first 100 days.
Headline payments revenue obscures net economics, loss-making cohorts, and true processor cost.
What is the normalized margin baseline, and which cost-side levers can support an EBITDA-lift case?
Contracts hide concentration, minimum commitments, portability limits, and exit exposure.
Which terms can constrain the thesis, alter the bid, or change the order of post-close work?
Management forecasts blend assumptions with evidence, making EBITDA upside look firmer than it is.
Which attachment, pricing, and take-rate assumptions remain defensible after the source data is normalized?
Straata turns the data room into one normalized baseline, a confidence-ranked upside and downside case, and the few watch items that can change the bid, market story, or first 100 days.
Investment Committee Pack
Fee anatomy, opportunity stack, contract constraints, and vendor-swap upside.
Management-projection decomposition and a defensibility test for the growth case.
EBITDA-lift case
Deal-killer flags
Post-close roadmap
The evidence, model, and decision surfaces stay linked so the analyst can trace each conclusion back to the data room.
Effective-cost and net-revenue baseline
Processor-contract, concentration, portability, and commitment review
Management-forecast and attachment-rate stress test
Scenario and EBITDA sizing with explicit evidence states
Optional vendor landscape and post-close sequence
Executive memo, model, watch-item register, and live walkthrough
The engagement compresses evidence collection, analysis, and sponsor review into the timeline available before close.
Confirm the target, decision deadline, available data, and whether cost-side lift, revenue-side validation, or both belong in scope.
Output / Scoped RequestCollect processor reporting, contracts, payments P&L inputs, cohort detail, and the management forecast used in underwriting.
Output / Evidence RegisterRebuild the baseline, test the selected analytical surfaces, size the case, and isolate the few issues that can move the deal.
Output / Linked AnalysisDeliver the executive memo, financial model, fee waterfall, and watch-item register in a form the analyst can use immediately.
Output / IC PackReview the evidence states, answer model questions, and align the sponsor on bid implications and the post-close sequence.
Output / Sponsor ReviewThe schedule flexes with data readiness and the transaction deadline. The final pack stays deliberately compressed for investment committee use.
Proof / Public-Safe And De-Identified
Each claim carries its evidence state. Identified means an opportunity surfaced by diligence, not a realized result. Executed means a completed engagement. Structural marks a fact about how the market or system works, not an outcome of one engagement.
Identified for a de-identified healthcare-vertical target ahead of close.
Documented diligence engagements across an aggregate sponsor set.
The analysis compounds: every diligence adds to the comp set the next one is priced against.
Cross-Portfolio Comp SetThese are separate, de-identified evidence points. The identified opportunity was not presented as a realized post-close result.
Fit Check
The strongest fit is a sponsor bidding on a vertical-SaaS target with embedded payments and a decision timeline measured in weeks. Best for sponsors, deal teams, management teams, and sell-side advisors. Choose this when payments can change underwriting, valuation, or the post-close plan.
For PE sponsors, deal teams, operating partners, management teams, and sell-side advisors when payments can change underwriting, valuation, or the post-close plan. Not for generic legal, tax, or quality-of-earnings diligence; opportunities without usable payments data; or implementation work.
| Buyer situation | Lane | Destination |
|---|---|---|
| Sponsor bidding a vertical-SaaS target | Buy-side diligence | This engagement |
| Banker running a sell-side process | Sell-side lane | This engagement |
| Operator seeking their own assessment | Diagnostic | Payments Diagnostic |
| Post-close optimization | Diagnostic or Residual Audit | Diagnostic / Residual Audit |
What Happens Next
The first call confirms the target, transaction timing, available payments evidence, and the analytical surface the investment committee needs.